DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
02 aug 2011 - 07:28
Statutaire naam
DSM B.V.
Titel
DSM reports strong Q2 results with solid growth
Bericht
Q2 EBITDA from continuing operations €339 million, above both Q2 2010 and Q1 2011
· Strong Life Sciences results driven by robust growth in Nutrition
· Very solid results in Materials Sciences due to pricing strength and volume growth
· Martek integration on track; excellent Q2 EBITDA performance
· EPS more than doubled, reflecting strong operating results, lower tax rate and one-off gains
· Interim dividend of €0.45 (+12.5%) representing one third of total dividend for 2010
· 2011 is expected to be a strong year; good progress towards achieving the 2013 targets
Datum laatste update: 28 december 2025